Patients must avoid purchasing medications from unregulated online sources, as these may be counterfeit, contaminated, or inappropriately stored, posing serious health risks
Who Should Not Switch to Tirzepatide Certain patients are not candidates for tirzepatide regardless of their prior GLP-1 use
Together, these developments underscore the dynamic interplay between medical advances, social attitudes, and the lived experiences of individuals with obesity, highlighting the need for continued dialog around the ethical, cultural, and clinical implications of obesity treatment
Logistical and Financial Challenges in Ongoing GLP-1/Peptide Treatment Supply shortages can occur when demand rises quickly
Based on these results Lilly plans to submit these data for global regulatory reviews